4 PhD opportunities at HT through DADS
Human Technopole is glad to announce the availability of 4 new fully funded PhD positions in the fields of Health Data Science, Population and Medical Genomics and Computational Biology. These positions aim to attract highly motivated graduates with strong academic backgrounds who are interested in cutting-edge research in data science.
The selected PhD candidates will enroll in the prestigious PhD Programme in Data Analytics and Decision Sciences (DADS) of the Polytechnic of Milan, will join research groups led by leading scientists and will have the opportunity to work on projects that integrate large-scale data to advance scientific understanding and healthcare outcomes. These projects will cover areas such as health data science, population and medical genomics, computational biology and the application of advanced data analytics to health records and biomolecular data.
The application process is competitive, targeting young scientists from both national and international communities.
Detailed information on the call and on the application process here. Deadline 1 July 2024.
Check out the HT groups participating in this frame:
- Zuccolo: Using Omics in health data science and epidemiological research
- Di Angelantonio/Ieva: Machine Learning for Polygenic Risk Prediction of Complex non-communicable Diseases
- Soranzo: Statistical genomics of population-scale single-cell data
- Sottoriva: Data Science for Single Cell Data in Cancer Research
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.